This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Guardian Pharmacy Services, Inc. Class A (GRDN) Receives a Buy from Jefferies

Tipranks - Tipranks - Tue Jun 16, 8:00AM CDT

In a report released today, Brian Tanquilut from Jefferies reiterated a Buy rating on Guardian Pharmacy Services, Inc. Class A, with a price target of $50.00.

Claim 55% Off TipRanks

Tanquilut covers the Healthcare sector, focusing on stocks such as Radnet, Brookdale Senior Living, and Acadia Healthcare. According to TipRanks, Tanquilut has an average return of 5.4% and a 50.71% success rate on recommended stocks.

Guardian Pharmacy Services, Inc. Class A has an analyst consensus of Strong Buy, with a price target consensus of $44.50.

See Insiders’ Hot Stocks on TipRanks >>

Based on Guardian Pharmacy Services, Inc. Class A’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $336.6 million and a net profit of $13.3 million. In comparison, last year the company earned a revenue of $329.31 million and had a net profit of $9.45 million

Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of GRDN in relation to earlier this year.

Read More on GRDN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).